Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
20.09.2018 23:27:00

The healthcare chatbots market is expected to reach USD 314.3 million by 2023 from USD 122.0 million by 2018, at a CAGR of 20.8% from 2018 to 2023

NEW YORK, Sept. 20, 2018 /PRNewswire/ --

Read the full report: https://www.reportlinker.com/p05500083


The healthcare chatbots market is expected to reach USD 314.3 million by 2023 from USD 122.0 million by 2018, at a CAGR of 20.8% from 2018 to 2023. The rising Internet connectivity and adoption of smart devices and the need for virtual assistance are factors driving the market. However, concerns regarding data privacy, lack of expertise for chatbot development, and lack of awareness pose a significant challenge to the market growth.

By application, the appointment scheduling & medical guidance segment is expected to grow at a higher CAGR during the forecast period.
By application, the healthcare chatbots market is segmented into symptom checking & medication assistance and appointment scheduling & medical guidance.The symptom checking & medication assistance segment is expected to lead the market in 2018.

The appointment scheduling & medical guidance segment is expected to grow at a higher CAGR during the forecast period as compared to the symptom checking & medication assistance segment, mainly due to the growing usage of healthcare chatbots by hospitals and clinics.

North America to witness high growth during the forecast period.
In 2018, Europe is estimated to account for the largest share of the market, followed by North America.However, North America is expected to register the highest CAGR during the forecast period.

The high growth in North America can be attributed to the growing number of therapy chatbots, rising adoption of smart devices, and growth in venture capital investments to develop advanced chatbots.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 28%; Tier 2 - 12%; Tier 3 - 60%.
• By Designation: C-level- 23%; D-level- 25%; others--52%.
• By Region: North America-59%; Europe-14%; Asia -22%; RoW-5%.

List of companies profiled in the report
• Your.MD (UK)
• HealthTap, Inc. (US)
• Sensely, Inc. (US)
• Buoy Health, Inc. (US)
• Infermedica (Poland)
• Babylon Healthcare Service Limited (UK)
• Baidu, Inc. (China)
• Ada Digital Health Ltd. (Germany)
• PACT Care BV (Netherlands)
• Woebot Labs, Inc. (US)
• GYANT.Com, Inc. (US)

Research Coverage:
The report provides an overview of the healthcare chatbots market.It aims at estimating the market size and growth potential of this market across different segments such as component, deployment model, application, end user, and region.

Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the healthcare chatbots market with closest approximations of revenues for the overall market and its subsegments.This report will help stakeholders understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies.

The report also will help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

Read the full report: https://www.reportlinker.com/p05500083

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-healthcare-chatbots-market-is-expected-to-reach-usd-314-3-million-by-2023-from-usd-122-0-million-by-2018--at-a-cagr-of-20-8-from-2018-to-2023--300716534.html

SOURCE Reportlinker

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!